KARILYN HAUT: Open Payments
NPI 1952634743 · SANTA MARIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$929 in 55 payments from 10 companies in 2025. Trend: 2023 $6,635 · 2024 $1,648 · 2025 $929
Food & beverage: $727Speaker / faculty: $117Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $279 |
| Janssen Biotech, Inc. | 14 | $194 |
| Lilly USA, LLC | 5 | $180 |
| UCB, Inc. | 4 | $94 |
| Organon LLC | 7 | $52 |
| GENZYME CORPORATION | 3 | $46 |
| PFIZER INC. | 1 | $24 |
| Verrica Pharmaceuticals Inc. | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
Products named: TREMFYA, SKYRIZI, EBGLYSS, Bimzelx, DUPIXENT, TALTZ, CIBINQO, YCANTH.
Industry payments across CA — which companies pay providers there.
